As of April 17, 2026, Exelixis's top three insider holders are David Edward Johnson (Director, 1.55Mn shares), Stelios Papadopoulos (Director, 1.19Mn shares), Christopher J. Senner (Evp And Cfo, 1.03Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| David Edward Johnson | - | 0 | 1,553,262 | 26 Nov, 2025 |
| Stelios Papadopoulos | - | 1,189,228 | 0 | 13 Nov, 2025 |
| Christopher J. Senner | Evp And Cfo | 1,028,110 | 0 | 02 Mar, 2026 |
| Jeffrey Hessekiel | Evp General Counsel | 693,396 | 0 | 16 May, 2025 |
| Gisela Schwab | Pres, Prod Dev Med Aff Cmo | 689,078 | 0 | 28 Jul, 2021 |
| Dana Aftab | Evp, Research And Development | 668,124 | 0 | 02 Mar, 2026 |
| Amy C. Peterson | Evp Prod Dev Med Aff Cmo | 465,393 | 0 | 16 May, 2025 |
| Lance Willsey | - | 424,415 | 0 | 13 May, 2022 |
| Patrick J. Haley | Evp, Commercial | 422,367 | 0 | 02 Mar, 2026 |
| Peter Lamb | Evp, Scientific Strategy Cso | 410,958 | 0 | 16 Dec, 2022 |
| Vicki L Goodman | Evp, Prod Dev Med Aff Cmo | 307,654 | 0 | 05 Apr, 2023 |
| Charles Cohen | - | 261,375 | 0 | 08 Jul, 2021 |
| George Poste | - | 178,832 | 0 | 30 May, 2025 |
| Brenda Hefti | Svp And General Counsel | 119,631 | 0 | 02 Mar, 2026 |
| Maria C Freire | - | 100,819 | 0 | 30 May, 2025 |
| Vincent T Marchesi | - | 93,989 | 0 | 27 May, 2022 |
| Alan M Garber | - | 35,703 | 0 | 25 Mar, 2024 |
| Mary C Beckerle | - | 21,380 | 0 | 13 Nov, 2025 |
| Bob Oliver | - | 21,120 | 0 | 18 Feb, 2026 |
| Carl B Feldbaum | - | 18,701 | 0 | 10 Feb, 2023 |
| David Edward Johnson | - | 18,176 | 0 | 02 Jun, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 24 Feb, 2026 | Michael Morrissey | Common Stock | D | 100,278 | $0.00 | 1,989,956 | I | G |
| 26 Feb, 2026 | Patrick J. Haley | Common Stock | A | 40,459 | $0.00 | 422,367 | D | A |
| 26 Feb, 2026 | Dana Aftab | Common Stock | A | 52,018 | $0.00 | 668,124 | D | A |
| 26 Feb, 2026 | Brenda Hefti | Common Stock | A | 23,119 | $0.00 | 119,631 | D | A |
| 26 Feb, 2026 | Christopher J. Senner | Common Stock | A | 52,018 | $0.00 | 1,028,110 | D | A |
| 26 Feb, 2026 | Michael Morrissey | Common Stock | A | 160,437 | $0.00 | 1,614,552 | D | A |
| 24 Feb, 2026 | Dana Aftab | Common Stock | D | 47,918 | $44.50 | 616,106 | D | S |
| 19 Feb, 2026 | Dana Aftab | Common Stock | D | 29,873 | $44.35 | 664,024 | D | S |
| 15 Feb, 2026 | Dana Aftab | Common Stock | D | 26,485 | $43.92 | 706,617 | D | F |
| 13 Feb, 2026 | Michael Morrissey | Common Stock | A | 494,700 | $21.31 | 2,319,941 | D | M |
| 13 Feb, 2026 | Bob Oliver | Common Stock | A | 9,088 | $19.28 | 51,370 | D | M |
| 15 Feb, 2026 | Patrick J. Haley | Common Stock | D | 31,483 | $43.92 | 449,722 | D | F |
| 15 Feb, 2026 | Brenda Hefti | Common Stock | D | 5,430 | $43.92 | 115,181 | D | F |
| 13 Feb, 2026 | Christopher J. Senner | Common Stock | D | 34,278 | $43.00 | 1,042,579 | D | S |
| 15 Feb, 2026 | Christopher J. Senner | Common Stock | D | 35,870 | $43.92 | 1,006,709 | D | F |
| 17 Feb, 2026 | Patrick J. Haley | Common Stock | D | 3,036 | $43.84 | 446,686 | D | S |
| 13 Feb, 2026 | Michael Morrissey | Common Stock | D | 369,606 | $43.92 | 1,950,335 | D | F |
| 13 Feb, 2026 | Bob Oliver | Common Stock | D | 9,088 | $43.61 | 42,282 | D | S |
| 15 Feb, 2026 | Dana Aftab | Common Stock | D | 12,720 | $43.92 | 693,897 | D | F |
| 18 Feb, 2026 | Brenda Hefti | Common Stock | D | 18,669 | $44.01 | 96,512 | D | S |